Victor Golmer
- The US FDA has approved an oral version of Novo Nordisk’s (NVO) blockbuster weight loss therapy, Wegovy (semaglutide).
- The Wegovy pill is the first GLP-1 oral treatment approved for obesity.
- Approval was based on results of the OASIS 4 trial, which
